Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that it enclosed its press release titled ‘Sun Pharma to Acquire Checkpoint Therapeutics’. The Press Release shall be released after filing this intimation. Annexure A, enclosed, provides the particulars of the disclosure required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Part A of Schedule III.

The above information is a part of company’s filings submitted to BSE.